These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11379848)

  • 1. Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report.
    Grant JE
    J Clin Psychiatry; 2001 Apr; 62(4):297-8. PubMed ID: 11379848
    [No Abstract]   [Full Text] [Related]  

  • 2. Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment.
    Crocq MA; Leclercq P; Guillon MS; Bailey PE
    Eur Psychiatry; 2002 Sep; 17(5):296-7. PubMed ID: 12381502
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
    Poyurovsky M; Kurs R; Weizman A
    J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
    Marazziti D; Pallanti S
    Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine treatment of obsessive-compulsive disorder.
    Degner D; Bleich S; Kornhuber J; Rüther E
    Can J Psychiatry; 2000 May; 45(4):393. PubMed ID: 10813075
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose olanzapine for self-mutilation behavior in patients with borderline personality disorder.
    Hough DW
    J Clin Psychiatry; 2001 Apr; 62(4):296-7. PubMed ID: 11379847
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.
    Francobandiera G
    Can J Psychiatry; 2001 May; 46(4):356-8. PubMed ID: 11387793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of combining lithium with olanzapine in the treatment of resistant schizophrenia.
    Martín JC; Palenciano G; Pérez R
    J Clin Psychiatry; 2000 Dec; 61(12):948. PubMed ID: 11206602
    [No Abstract]   [Full Text] [Related]  

  • 9. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo.
    Baker RW; Ames D; Umbricht DS; Chengappa KN; Schooler NR
    Psychopharmacol Bull; 1996; 32(1):89-93. PubMed ID: 8927681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms.
    Poyurovsky M; Dorfman-Etrog P; Hermesh H; Munitz H; Tollefson GD; Weizman A
    Int Clin Psychopharmacol; 2000 May; 15(3):169-73. PubMed ID: 10870875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder.
    Potenza MN; Wasylink S; Longhurst JG; Epperson CN; McDougle CJ
    J Clin Psychopharmacol; 1998 Oct; 18(5):423-4. PubMed ID: 9790164
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of high-dose olanzapine in refractory psychosis.
    Reich J
    Am J Psychiatry; 1999 Apr; 156(4):661. PubMed ID: 10200755
    [No Abstract]   [Full Text] [Related]  

  • 13. Antidepressant augmentation with low-dose olanzapine in obsessive-compulsive disorder.
    Marusic A; Farmer A
    Br J Psychiatry; 2000 Dec; 177():567. PubMed ID: 11270368
    [No Abstract]   [Full Text] [Related]  

  • 14. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
    Bogetto F; Bellino S; Vaschetto P; Ziero S
    Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine-induced manic-like syndrome.
    Lindenmayer JP; Klebanov R
    J Clin Psychiatry; 1998 Jun; 59(6):318-9. PubMed ID: 9671347
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of preexisting diabetes with olanzapine.
    Littrell KH; Petty RG; Peabody CD; Hilligoss NM; Johnson CG
    J Clin Psychiatry; 2001 Sep; 62(9):733-4. PubMed ID: 11681771
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine-induced obsessive-compulsive disorder.
    Mottard JP; de la Sablonnière JF
    Am J Psychiatry; 1999 May; 156(5):799-800. PubMed ID: 10327925
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine for cocaine craving and relapse prevention in 2 patients.
    Longo LP
    J Clin Psychiatry; 2002 Jul; 63(7):595-6. PubMed ID: 12143917
    [No Abstract]   [Full Text] [Related]  

  • 19. Worsening of obsessive-compulsive symptoms following treatment with olanzapine.
    Morrison D; Clark D; Goldfarb E; McCoy L
    Am J Psychiatry; 1998 Jun; 155(6):855. PubMed ID: 9619164
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.